Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 11 » Issue 1

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)

Total article views   HTML views PDF downloads Totals
29,501 Dovepress* 22,978+ 2,834 25,812
PubMed Central* 6,523 2,807 9,330
Totals 29,501 5,641 35,142
*Since 3 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 2 6

View citations on PubMed Central and Google Scholar